戻る Agenda
[S10] Initiatives For The Future of Digital Health: Utilizing Digitalized Product Information/Labeling for Healthcare Professionals and Patients
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan
Digitalized product information, part of the evolving global movement toward digitalization of healthcare, can improve health literacy for patients and enable patients to choose their own healthcare more proactively. Per the revised regulation for labeling implemented in April 2019, XML conversion has been required for labeling information in Japan. XML converted labeling, already implemented in the US, is the backbone of digitalized product information; other western countries have also started to consider XML conversion of labeling. This session will look ahead to the future of digital health by comparing these initiatives in Japan, the US, and the EU, and discussing utilization of digitalized product information/labeling issued by regulatory authorities and companies for patients and healthcare
Speaker(s)
The Electronic Product Information (ePI)-Initiative of the European Union
Peter Bachmann
Federal Institute for Drugs and Medical Devices (BfArM), Germany
Deputy-Head, European Union and International Affairs
Current Situation and the Future of e-Labeling Utilization in Japan from Regulator’s Point of View
Takashi Tai
Ministry of Health, Labour and Welfare (MHLW), Japan
Deputy Director, Pharmaceutical Safety and Environmental Health Bureau
Advancements in e-labeling technologies and their global implementation
Shimon Yoshida, PhD
Pfizer Inc, United Kingdom
Executive Director, International Labeling Group, Global Regulatory Affairs